filgotinib (GLPG0634) - Gilead
Filgotinib: Completion of enrollment in P3 DIVERSITY trial (NCT02914561) for Crohn's disease in Q3 2020 (Gilead) - Jul 31, 2019 - Q2 2019 Results 
Enrollment status
http://investors.gilead.com/static-files/575b248b-e0bc-4220-9386-e3f555cacc79
 
Jul 31, 2019
 
 
867cec39-919b-4115-8faf-61e0195f2aaf.jpg